sk&f-38393 has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felder, CC; Ma, AL; Singer-Lahat, D | 1 |
| Hama, H; Watanabe, K; Yamaguchi, K | 1 |
2 other study(ies) available for sk&f-38393 and dinoprostone
| Article | Year |
|---|---|
Independent induction of morphological transformation of CHO cells by receptor-activated cyclic AMP synthesis or by receptor-operated calcium influx.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arginine Vasopressin; Calcium; Carbachol; Cell Line, Transformed; Cell Transformation, Neoplastic; CHO Cells; Cricetinae; Cyclic AMP; Dinoprostone; Dopamine Agonists; GTP-Binding Proteins; Inositol 1,4,5-Trisphosphate; Kinetics; Receptors, Cell Surface; Receptors, Dopamine D1; Receptors, Muscarinic; Receptors, Vasopressin; Signal Transduction; Time Factors | 1996 |
Negligible role of catecholaminergic receptors in the anteroventral third ventricular region in mediating vasopressin-releasing and cardiovascular actions of prostaglandin E2.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Blood Pressure; Cardiotonic Agents; Chlorides; Consciousness; Dinoprostone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Heart Rate; Injections, Intraventricular; Isoproterenol; Male; Osmolar Concentration; Oxytocics; Potassium; Rats; Rats, Wistar; Receptors, Dopamine D1; Sodium; Sulpiride; Third Ventricle; Vasopressins | 1999 |